16673-34-0
16673-34-0
Chemical Structure
NLRP3-IN-2
- CAS No.: 16673-34-0
- Formula:C16H17ClN2O4S
- Molecular Weight:368.84
IUPAC Name: 5-chloro-2-methoxy-N-(4-sulfamoylphenethyl)benzamide
InChIKey: KVWWTCSJLGHLRM-UHFFFAOYSA-N
SMILES: O=C(NCCC1=CC=C(S(=O)(N)=O)C=C1)C2=CC(Cl)=CC=C2OC
Biological Activity: NLRP3-IN-2, an intermediate substrate in the synthesis of glyburide, inhibits the formation of the NLRP3 inflammasome in cardiomyocytes and limits the infarct size following myocardial ischemia/reperfusion in the mouse, without affecting glucose metabolism[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
NLRP3-IN-2 | 98.00% | NLRP3-IN-2, an intermediate substrate in the synthesis of glyburide, inhibits the formation of the NLRP3 inflammasome in cardiomyocytes and limits the infarct size following myocardial ischemia/reperfusion in the mouse, without affecting glucose metabolism. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
NLRP3-IN-2 (Standard) | ≥98% | NLRP3-IN-2 (Standard) is the analytical standard of NLRP3-IN-2. This product is intended for research and analytical applications. NLRP3-IN-2, an intermediate substrate in the synthesis of glyburide, inhibits the formation of the NLRP3 inflammasome in cardiomyocytes and limits the infarct size following myocardial ischemia/reperfusion in the mouse, without affecting glucose metabolism. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.88
HY-120007JC124 -
Similarity Score 0.88
HY-117432JC-171 -
Similarity Score 0.81
HY-15210Meglitinide -
Similarity Score 0.70
HY-15206Glibenclamide -
Similarity Score 0.69
HY-1171604-trans-Hydroxy-glibenclamide -
Similarity Score 0.69
HY-124057RO5126946 -
Similarity Score 0.68
HY-W157980Glipizide impurity 2 -
Similarity Score 0.68
HY-Z8216Glipizide impurity 3 -
Similarity Score 0.68
HY-1268453-cis-Hydroxyglibenclamide -
Explore the MedChemAI to find more analogs
